References
- Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
- Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle and Nerve. 2007;35:291–302.
- Zhai P, Pagan F, Statland J, Butman JA, Floeter MK. Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes. Neurology. 2003;60:1258–65.
- Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurology. 2007;64:232–6.
- Kuipers-Upmeijer J, de Jager AE, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry. 2001;71:615–20.
- Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115: 495–520.
- Ellis CM, Suckling J, , Amaro E JrBullmore ET, Simmons A, Williams SC, Leigh PN. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology. 2001;57:571–8.
- van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extramotor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009;19:53–8.
- Koenigs M, Huey ED, Calamia M, Raymont V, Tranel D, Grafman J. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J Neuroscience. 2008;8:12341–8.
- First MB, Spitzer RL, Gibbon M, Williams JBW. Structured cinical iterview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York: NY State Psychiatric Institute, Biometrics Research Dept; 1995.
- Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003; 60:1094–7.
- Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
- Bak TH, Hodges JR. Motor neuron disease, dementia, and aphasia: coincidence, co-occurrence, or continuum? J Neurol. 2001;248:260–70.
- Caselli RJ, Simth BE, Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology. 1995; 45:2005–9.
- Tartaglia MC, Laluz V, Rowe A, Findlater K, Lee DH, Kennedy K, . Brain atrophy in primary lateral sclerosis. Neurology. 2009;72:1236–41.
- Piquard A, Le Forestier N, Baudoin-Madec V, Delagillo D, Salachas F, Pradat PF, . Neuropsychological changes in patients with primary lateral sclerosis. Amyotroph Lateral Scler. 2006;7:150–60.
- Houpt JL, Gould BS, Norris FH Jr. Psychological characteristics of patients with amyotrophic lateral sclerosis (ALS). Psychosom Med. 1977;39:299–303.
- Schiffer RB, Babigian HM. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis. An epidemiologic study. Arch Neurol. 1984;41: 1067–9.
- Newrick PG, Langton-Hewer R. Motor neuron disease: can we do better? A study of 42 patients. Br Med J. (Clin Res Ed) 1984;289:539–42.
- Bocker FM, Seibold I, Neundorfer B. Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr. 1990;58: 224–36.
- Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neuron disease. Psychol Med. 1994;24: 625–32.
- Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illnesses. J Neurol Sci. 1997;152 (Suppl 1): S75–9.
- Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neuron disease. J Neurol Sci. 1998;160 (Suppl 1): S53–6.
- Ganzini L, Johnston WS, McFarland BH, Tolle SW, Lee MA. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med. 1998;339:967–73.
- Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.
- Miller RG, , Anderson FA JrBradley WG, Brooks BR, Mitsumoto H, Munsat TL, . The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology. 2000;54:53–7.
- Bungener C, Piquard A, Pradat PF, Salachas F, Meininger V, Lacomblez L. Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6:221–5.
- Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, . Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65: 62–7.
- Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. European Journal of Neurology. 2007;14:993–1001.
- Hammer EM, Hacker S, Hautzinger M, Meyer TD, Kubler A. Validity of the ALS Depression Inventory (ADI-12): a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord. 2008;109: 213–9.
- Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14:82–99.
- Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–37. Epub 2006, Sep 26.
- Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer. 2007;110:1665–76. Review.
- Olney RK, Lomen-Hoerth C. Exit strategies in ALS: an influence of depression or despair? Neurology. 2005;65: 9–10.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
- Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, . Consensus criteria for the diagnosis of frontotemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
- Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery. Neurology. 2000;55:1621–6.
- Lund/Manchester. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57:416–8.
- Crum RM, Anthony JC, Bassett SS, Folstein MF. Population based norms for the Mini-Mental State examination by age and education level. JAMA. 1993;269:2386–91.
- Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, de Kosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA. 2002;288: 1475.
- Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151:979.
- Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, . Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry. 1996;53:175–82.
- Anderson KE, Marder KS. An overview of psychiatric symptoms in Huntington’s disease. Curr Psychiatry Rep. 2001;5: 379–88.